Yuliang Wang
Nanjing Medical University
10 Papers
9 Citations
Yuliang Wang is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
High-sensitivity troponin T release profile in off-pump coronary artery bypass grafting patients with normal postoperative course
Wen Ge,Chang Gu,Chao Chen,Wangwang Chen,Zhengqiang Cang,Yuliang Wang,Chennan Shi,Yangyang Zhang +7 more
TL;DR: The high-sensitivity troponin T (hs-TnT) release profile in off-pump coronary artery bypass grafting patients with normal postoperative course was investigated to provide some useful information for future clinical studies of myocardial biomarkers after OPCABG.
Proteomic Analysis of Atrial Appendages Revealed the Pathophysiological Changes of Atrial Fibrillation
Ban Liu,Xiang Li,Cuimei Zhao,Yuliang Wang,Mengwei Lv,Mengwei Lv,Xin Shi,Chunyan Han,Pratik Pandey,Chunhua Qian,Changfa Guo,Yangyang Zhang +11 more
TL;DR: Differentially expressed proteins involved in the development of structural remodeling in atrial fibrillation patients were identified and may provide a new perspective for the pathological process of AF, and may enable useful targets for drug interference.
GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway
Dawei Rong,Yuliang Wang,Lei Liu,H. Cao,Tian Huang,Hanyuan Liu,Xi-shang Hao,Guangshun Sun,Guoqiang Sun,Zhiying Zheng,Junwei Kang,Yongxiang Xia,Ziyi Chen,Weiwei Tang,Xuehao Wang +14 more
TL;DR: In this paper , the effects of GLI-similar 1 (GLIS1) on modulating the anticancer potency of CD8+ T cells in hepatocellular carcinoma (HCC) were explored.
Feasibility and efficacy of simultaneous off-pump coronary artery bypass grafting and esophagectomy in elderly patients
Ban Liu,Chang Gu,Yuliang Wang,Xiaowei Wang,Wen Ge,Lingtong Shan,Yujian Wei,Xiaohan Xu,Yangyang Zhang +8 more
TL;DR: The combined procedure of OPCABG and esophagectomy is a safe and effective treatment option for patients with severe CAD and Esophageal cancer.
Impact of the COVID-19 pandemic and the dynamic COVID-zero strategy on HIV incidence and mortality in China
Lan Wang,Na Zhao,Yuliang Wang,Kaili Sun,Yike Wang,Shufang Huang,Feng Yao,Xiangyu Guo,Yun Fang Yang,Chenjin Ma,Shelan Liu +10 more
TL;DR: Wang et al. as discussed by the authors used a two-ratio Z-test to compare the observed and predicted HIV values in 2020-2022 with those in 2015-2019, and found that China's dynamic COVID-zero strategy may have partly disrupted HIV transmission and further slowed down its growth.